Trials / Completed
CompletedNCT05992701
Effectiveness and Safety of Directional Deep Brain Stimulation for Parkinson's Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Beijing Pins Medical Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate the safety and effectiveness of the PINS Deep Brain Stimulation (DBS) system, including the G107R/G107 IPG, L305/L306 directional leads, E204 extensions and related system components.
Detailed description
This is a prospective, open label, non-randomized study. The study will evaluate the clinical outcome and possible adverse effects of the directional DBS treatment. The following data will be collected: therapeutic window, Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating (MDS-UPDRS) Part III scores, Parkinson's Disease Questionnaire (PDQ-39) summary scores, total electrical energy delivered, the dosage of anti-parkinsonian medications, on time(h/d) without troublesome dyskinesia, and adverse events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Directional deep brain stimualtion | Directional deep brain stimualtion in the treatment of Parkinson's disease using L305/L306 leads and G107R/G107 implanted pulse generators (Beijing Pins Medical Co.). |
Timeline
- Start date
- 2021-07-28
- Primary completion
- 2023-11-13
- Completion
- 2023-12-23
- First posted
- 2023-08-15
- Last updated
- 2025-12-10
Locations
9 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05992701. Inclusion in this directory is not an endorsement.